Market Highlights
Periodontal Therapeutics Market Share is projected to
reach USD 0.73 Billion by 2032 exhibiting a compound annual growth rate (CAGR)
of 10.3% during the forecast period (2023 - 2032).
Periodontal disease is an infection that occurs around the
teeth which include gums, periodontal ligament and alveolar bone. The earliest
stage of periodontal is gingivitis infection that affects the gums. Periodontal
is mostly caused by bacteria in dental plaque sticky substance that forms on
teeth. Although bacterial plaque is the main cause of periodontal disease
several other factors such as medication, other diseases, and oral habit also
contributes to periodontal disease.
Periodontal Therapeutics Market Research and Report Analysis: By Type (Chronic Periodontitis Aggressive Periodontitis and Necrotizing Periodontal), by Treatment (Systematic Antibiotics and Others), by End-Users (Dental Hospital and Others)-Forecast Till 2032
The increasing demand for local antibiotic has resulted in a
rise in research and development of local antibiotic. Owing to the increasing
incidences of diabetic patients there is a rise in the periodontal therapeutic
market. Whereas the rising prevalence of periodontal disorders and
technological advancement in therapeutics are some factors positively impacting
on the growth of this market. By segment systemic antibiotic will holds the
largest share of the market during the forecast period. Whereas local antibiotic
segment is expected to grow at the fastest rate due to decreasing chances of
formation of resistant bacteria following few side effects. Increasing
expenditure on oral health care services by the government especially in
developed countries is anticipated to boost the treatment market for the periodontal
disorder.
Key Players
Some of the Global Periodontal Therapeutics Market Players
are,
Tolmar Inc,
Eli Lilly & Company,
Align Technology Inc.,
Dentsply International,
3M-ESPE,
Ultradent Products Inc.,
Nobel Biocare Holdings AG,
Glidewell Laboratories, Inc.,
Orapharma,
Kaken Pharmaceutical,
Valeant Pharmaceuticals Int. Inc,
Den-Mat Holdings,
Mallinckrodt Pharmaceuticals,
Purdue Pharma L.P.,
Teva Pharmaceutical Industries Limited, and
Fibrocell Sciences Inc.
Segmentation
The global Periodontal
Therapeutics Market Trends Research has been segmented on basis of
treatment type, types of periodontal and end-users.
·
Based on treatment types market is
segmented into two segments such as systematic antibiotics and local
antibiotics. Systematic antibiotics are further sub-segmented into doxycycline,
minocycline, metronidazole, and others. Local antibiotics are further segmented
into arestin, chlorhexidine, and others.
·
On basis of types of periodontal, the
market is segmented into three types such as chronic periodontitis, aggressive
periodontitis, necrotizing periodontal disease.
·
On basis of end-user market is further is
segmented into dental clinics and hospitals
·
The market has been segmented, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
A booming need for more oral hygiene appeal in the field of
periodontal treatment is being observed worldwide. The rising awareness
regarding oral hygiene and increasing incidence of the periodontal disorder
among people are factors responsible for the growth of the Periodontal
Therapeutics Market Outlook in this region.
The market in the Americas is expected to boost the global
periodontal therapeutic market owing to technological advancement and
increasing incidences of the periodontal disorder among diabetic patients.
According to recent findings from the Centers for Disease Control and
Prevention (CDC), half of Americans aged 30 or older have periodontitis, the
more advanced form of periodontal disease. This equals approximately 64.7
million Americans. This is largely attributed to the accessibility of an urban
healthcare infrastructure. The European market is expected to be the
second-largest due to government funding and support from the healthcare sector
coupled with the rising prevalence of the periodontal disorder. However,
Asia-Pacific is projected to dominate in terms of growth rate over the forecast
period owing to rising investment towards R&D activities and unhealthy
lifestyle which are resulting in an increased prevalence of obesity. Rising
geriatric population and the increasing prevalence of diabetes in this region
have a positive influence on the development of the periodontal therapeutic
market in this region. The Middle East
and Africa account for the smallest share due to lack of medical technology and
poor medical facilities. Emerging economies such as India and China are leading
to growth in demand for periodontal therapeutic owing to increasing number of
healthcare awareness programs, government investment in healthcare and
favorable healthcare insurance coverage. National Oral Health Programmed (NOHP)
was conceptualized by the Indian Dental Association to ensure optimal oral
health for all by increasing awareness, assuring excellent service and
high-quality dental care
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
